Skip to main content
. 2024 Oct 8;25:665. doi: 10.1186/s13063-024-08508-9

Table 3.

Analysis of methods for estimating appropriate planned accrual periods

Proportion of trials within planned accrual period (trials number) Univariable analysis Multivariable analysis
OR 95% CI P value OR 95% CI P value
Consideration of the patient accrual pace of past trials
 Yes 40% (25/63) 3.41 1.73–6.73 <0.001 3.51 1.73–7.10 <0.001
 No 16% (22/136) 1 1
Survey evaluation of the accrual pace of the participating institutions
 Yes 22% (22/100) 0.84 0.43–1.61 0.589 1.12 0.56–2.26 0.751
 No 25% (25/99) 1 1